Contraindicated. Coadministration not advisable; potent cytochrome P450 enzyme inducers minimize systemic exposure to roflumilast and should decrease the therapeutic performanceWatch Intently (1)somatropin will lessen the extent or outcome of phenobarbital by affecting hepatic/intestinal enzyme CYP3A4 metabolism.Picked from data incorporated with p